Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Calcipotriol vs Intralesional Corticosteroids for Alopecia Areata
NCT07453238Phase 4Not yet recruiting
- Sponsor
- Hayatabad Medical Complex
- Start
- Oct 2026
- Primary completion
- Mar 2027
- Modality
- Orthosteric Ligands
01
Overview
Phase 4, randomised, open-label trial of AKP01 in alopecia areata (2 arms), sponsored by Hayatabad Medical Complex. Primary endpoint: Severity of Alopecia Tool Score at 12 weeks. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
AKP01
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT07453238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07453238.